English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

ALK mutations conferring differential resistance to structurally diverse ALK inhibitors

MPS-Authors
/persons/resource/persons147193

Heuckmann,  Johannes M.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Hölzel,  Michael
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States d Chemical Genomics Center, Max Planck Society, Dortmund, Germany e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;

/persons/resource/persons147301

Sos,  Martin L.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147194

Heynck,  Stefanie
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147128

Balke-Want,  Hyatt
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147213

Koker,  Mirjam
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147255

Peifer,  Martin
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147338

Weiss,  Jonathan
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Lovly,  Christine M.
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States d Chemical Genomics Center, Max Planck Society, Dortmund, Germany e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;

Grütter,  Christian
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States d Chemical Genomics Center, Max Planck Society, Dortmund, Germany e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;

Rauh,  Daniel
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States d Chemical Genomics Center, Max Planck Society, Dortmund, Germany e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;

Pao,  William
a Department I of Internal Medicine, Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany b Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, Netherlands c Department of Medicine, Vanderbilt University, School of Medicine, Nashville, TN, United States d Chemical Genomics Center, Max Planck Society, Dortmund, Germany e Technical University Dortmund, Fakultät Chemie, Dortmund, Germany f Institut für Klinische Chemie und Klinische Pharmakologie, Zentrallabor, Universitätsklinikum Bonn, Sigmund-Freud- Str. 25, Bonn, Germany;

/persons/resource/persons147315

Thomas,  Roman K.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Heuckmann, J. M., Hölzel, M., Sos, M. L., Heynck, S., Balke-Want, H., Koker, M., et al. (2011). ALK mutations conferring differential resistance to structurally diverse ALK inhibitors. Clinical Cancer Research, 17(23), 7394-7401. doi:10.1158/1078-0432.CCR-11-1648.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0026-D21D-6
Abstract
©2011 AACR.